AR and prostate cancer: Since androgen is recognized to be the most important growth-promoting hormone in prostate cancer initiation and progression, androgen depletion therapy (ADT) in the form of medical or surgical castration to down-regulate androgen receptor (AR) signaling, is the recommended hormonal therapy for advanced or metastatic prostate cancer palliation [2].